Maria Victoria Hospital is hospital in Turin, Italy. The construction of the hospital began in 1883, on some land donated by Giuseppe Berruti. In 1885 there was the inauguration and at the beginning the hospital consisted of three pavilions and twelve beds.

During the past decade, Ospedale Maria Vittoria conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Maria Vittoria" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Careggi Hospital" with 1 trials sponsored, "Gruppo di Ricerca GISSI" with 1 trials sponsored and "Maria Vittoria Hospital" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Maria Vittoria" #1 collaborator was "Heart Care Foundation" with 1 trials as a collaborator and "University of Florence" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Maria Vittoria" are "Heart Failure" (3 trials), "Coronary Artery Disease" (2 trials), "Coronary Artery Restenosis" (2 trials), "Coronary Artery Stenosis" (2 trials) and "Coronary Disease" (2 trials). Many other conditions were trialed in "Ospedale Maria Vittoria" in a lesser frequency.

Most popular intervention types in "Ospedale Maria Vittoria" are "Device" (5 trials), "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ASA 100 mg" (1 trials), "CRT-D" (1 trials), "Commercial membrane for Extracorporeal Blood Purification Therapy (EBPT)" (1 trials), "Coronary artery placement of a drug-eluting stent" (1 trials) and "Cyclosporine A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Maria Vittoria" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Maria Vittoria". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Ospedale Maria Vittoria, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Maria Vittoria, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".